(Name of the Issuer) | ||||
HCA Inc.
|
Jack O. Bovender, Jr. Richard M. Bracken |
Thomas F. Frist, Jr., M.D. Thomas F. Frist III Frisco, Inc. Frisco Partners Hercules Holding II, LLC Hercules Acquisition Corporation |
||
Bain Capital Fund IX, L.P. KKR Millennium Fund L.P. KKR 2006 Fund L.P. |
||||
ML Global Private Equity Fund, L.P. | ||||
(Name of Person(s) Filing Statement) |
James
H. Cheek, III, Esq.
|
Creighton OM. Condon, Esq. | James C. Morphy, Esq. | David J. Sorkin, Esq. | |||||
J.
Page Davidson, Esq.
|
Clare OBrien, Esq. | John Evangelakos, Esq. | Simpson Thacher & Bartlett LLP | |||||
Bass, Berry & Sims PLC
|
Shearman & Sterling LLP | Sullivan & Cromwell LLP | 425 Lexington Avenue | |||||
315 Deaderick Street
|
599 Lexington Avenue | 125 Broad Street | New York, NY 10017 | |||||
Suite 2700
|
New York, NY 10022 | New York, NY 10004 | (212) 455-2000 | |||||
Nashville, Tennessee 37238
|
(212) 848-4000 | (212) 558-4000 | ||||||
(615) 742-6200
|
þ
|
a. | The filing of solicitation materials or an information statement subject to Regulation 14A, Regulation 14-C or Rule 13e-3(c) under the Securities Exchange Act of 1934. | ||
o
|
b. | The filing of a registration statement under the Securities Act of 1933. | ||
o
|
c. | A tender offer. | ||
o
|
d. | None of the above. |
Transaction Valuation* $21,279,088,602.46 |
Amount of Filing Fee** $2,276,862.48 |
* | Calculated solely for purposes of determining the filing fee. The transaction value was determined based upon the sum of (a) $51.00 per share of 409,547,671 shares of HCA voting and nonvoting common stock, par value $.01 per share (the HCA Common Stock), (b) $51.00 minus the weighted average exercise price of $39.40 per share of outstanding options to purchase 24,941,169 shares of HCA Common Stock, (c) $51.00 minus the weighted average exercise price of $20.34 per share of outstanding options to purchase 3,104,006 shares of HCA Common Stock, (d) $51.00 per share of restricted share units with respect to 134,261 shares of HCA Common Stock; and (e) $51.00 minus the exercise price of $2.29 per share of outstanding warrants to purchase 16,910 shares of HCA Common Stock. | |
** | The filing fee, calculated in accordance with Exchange Act Rule 0-11(c)(1), was calculated by multiplying the transaction value by 0.000107. | |
þ | Check box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
(a)(4) | Press Release, dated November 17, 2006 | |||
HCA INC. | ||||||
By: | /s/ R. Milton Johnson | |||||
Name: | R. Milton Johnson | |||||
Title: | Executive Vice President | |||||
and Chief Financial Officer | ||||||
JACK O. BOVENDER, JR. | ||||||
/s/ Jack O. Bovender, Jr. | ||||||
Jack O. Bovender, Jr. | ||||||
RICHARD M. BRACKEN | ||||||
/s/ Richard M. Bracken | ||||||
Richard M. Bracken | ||||||
THOMAS F. FRIST, JR., M.D. | ||||||
/s/ Thomas F. Frist, Jr., M.D. | ||||||
Thomas F. Frist, Jr., M.D. | ||||||
THOMAS F. FRIST III | ||||||
/s/ Thomas F. Frist III | ||||||
Thomas F. Frist III |
FRISCO, INC. |
||||||
By: | /s/ Thomas F. Frist, Jr., M.D. | |||||
Name: | Thomas F. Frist, Jr., M.D. | |||||
Title: | Authorized Person | |||||
FRISCO PARTNERS |
||||||
By: | /s/ Thomas F. Frist, Jr., M.D. | |||||
Name: | Thomas F. Frist, Jr., M.D. | |||||
Title: | Authorized Person |
HERCULES HOLDING II, LLC |
||||||
By: | /s/ Chris Gordon | |||||
Name: | Chris Gordon | |||||
Title: | President | |||||
HERCULES ACQUISITION CORPORATION |
||||||
By: | /s/ Chris Gordon | |||||
Name: | Chris Gordon | |||||
Title: | President | |||||
BAIN CAPITAL FUND IX, L.P. By: BAIN CAPITAL PARTNERS IX, L.P., its general partner |
||||||
By: BAIN CAPITAL INVESTORS, LLC, its general partner |
||||||
By: | /s/ Stephen G. Pagliuca | |||||
Name: | Stephen G. Pagliuca | |||||
Title: | Managing Director | |||||
KKR MILLENNIUM FUND L.P. By: KKR ASSOCIATES MILLENNIUM L.P., its general partner By: KKR MILLENNIUM GP LLC, its general partner |
||||||
By: | /s/ Michael W. Michelson | |||||
Name: | Michael W. Michelson | |||||
Title: | Member | |||||
KKR 2006 FUND L.P. By: KKR ASSOCIATES 2006 L.P., its general partner |
||||||
By: KKR 2006 GP LLC, its general partner |
||||||
By: | /s/ Michael W. Michelson | |||||
Name: | Michael W. Michelson | |||||
Title: | Member | |||||
ML GLOBAL PRIVATE EQUITY FUND, L.P. By: MLGPE LTD, its General Partner |
||||||
By: | /s/ Frank J. Marinaro | |||||
Name: | Frank J. Marinaro | |||||
Title: | Vice President and Secretary |
(a)(1) | Letter to Shareholders of HCA Inc., incorporated herein by reference to the Proxy Statement on Schedule 14A filed by HCA Inc. with the Securities and Exchange Commission on October 17, 2006 (as amended and as supplemented on November 8, 2006, the Proxy Statement) | |||
(a)(2) | Notice of Special Meeting of Shareholders of HCA Inc., incorporated herein by reference to the Proxy Statement | |||
(a)(3) | Proxy Statement of HCA Inc., incorporated herein by reference to the Proxy Statement | |||
(a)(4) | Press Release, dated November 17, 2006 | |||
(b)(1) | Debt Commitment Letter, dated as of July 24, 2006, among Hercules Holding II, LLC and Bank of America, N.A., Banc of America Bridge LLC, Banc of America Securities LLC, JPMorgan Chase Bank, N.A., J.P. Morgan Securities Inc., Citigroup Global Markets Inc., Merrill Lynch Capital Corporation and Merrill Lynch, Pierce, Fenner & Smith Incorporated (Merrill Lynch)* | |||
(c)(1) | Fairness Opinion of Credit Suisse Securities (USA) LLC, dated July 23, 2006, incorporated herein by reference to the Proxy Statement | |||
(c)(2) | Fairness Opinion of Morgan Stanley & Co. Incorporated, dated as of July 23, 2006, incorporated herein by reference to the Proxy Statement | |||
(c)(3) | Presentation of Credit Suisse Securities (USA) LLC and Morgan Stanley & Co. Incorporated to the Special Committee of the Board of Directors of HCA Inc., dated July 17, 2006* | |||
(c)(4) | Presentation of Credit Suisse Securities (USA) LLC and Morgan Stanley & Co. Incorporated to the Special Committee of the Board of Directors of HCA Inc., dated July 23, 2006* | |||
(c)(5) | Presentation of McKinsey & Company, Inc., dated July 17, 2006* | |||
(c)(6) | Presentation of Merrill Lynch to the Board of Directors of HCA Inc., dated May 25, 2006* | |||
(c)(7) | Presentation of Bain, KKR and Merrill Lynch Global Private Equity to Credit Suisse Securities (USA) LLC, Morgan Stanley & Co. Incorporated and Shearman & Sterling LLP, dated July 11, 2006** | |||
(c)(8) | Presentation of McKinsey & Company, Inc., dated July 11, 2006** | |||
(d)(1) | Agreement and Plan of Merger, dated July 24, 2006, between HCA Inc., Hercules Holding II, LLC and Hercules Acquisition Corporation, incorporated herein by reference to the Proxy Statement | |||
(d)(2) | Rollover Letter, dated July 24, 2006, between Frisco Partners, Frisco, Inc. and Hercules Holding II, LLC* | |||
(d)(3) | Letter, dated July 24, 2006, from Jack O. Bovender, Jr. to Hercules Holding II, LLC* | |||
(d)(4) | Letter, dated July 24, 2006, from Richard M. Bracken to Hercules Holding II, LLC* | |||
(d)(5) | Interim Investors Agreement, dated July 24, 2006, by and among Hercules Holdings II, LLC and the parties listed on the signature pages thereto* | |||
(d)(6) | Letter, dated July 24, 2006, between Bain Capital Fund IX, L.P. and Hercules Holding II, LLC** | |||
(d)(7) | Letter, dated July 24, 2006, between KKR Millennum Fund L.P., KKR 2006 Fund L.P. (as assignee of the rights and obligations of KKR PEI Investments, L.P.) and Hercules Holding II, LLC** | |||
(d)(8) | Letter, dated July 24, 2006, between ML Global Private Equity Fund, L.P. and Hercules Holding II, LLC** | |||
(f)(1) | Section 262 of the General Corporation Law of the State of Delaware, incorporated herein by reference to Annex D of the Proxy Statement | |||
(g) | None |
*
Previously filed on August 9, 2006
|
||||
**
Previously filed on September 18, 2006
|